Original language | English |
---|---|
Pages (from-to) | 195-197 |
Number of pages | 3 |
Journal | American Heart Journal |
Volume | 85 |
Issue number | 2-3 |
Publication status | Published - 2002 |
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
PR Kalra, J Moon, AJ Coats
Research output: Contribution to journal › Article
272
Citations
(Scopus)